Align Technology Provides Update Regarding Patent Case Against ClearCorrect

Marketwired

SAN JOSE, CA--(Marketwired - Mar 21, 2014) - Align Technology, Inc. (NASDAQ: ALGN) today announced that the International Trade Commission ("ITC") extended the target date for completion of its review of the Initial Determination in the ClearCorrect investigation. The new target date is April 3, 2014. Although the Commission did not indicate the reason for the extension, the fact that the Commission received significant public comment could explain the brief further delay.

Align initially filed an ITC complaint against ClearCorrect on March 1, 2012, asserting that ClearCorrect's aligners are made using digital data and treatment plans imported from Pakistan that infringe Align's patents. Align also has a patent infringement action pending against ClearCorrect in the United States District Court for the Southern District of Texas alleging infringement of nine Align patents, including four additional patents not included in the ITC litigation. In May 2013, the Administrative Law Judge ("ALJ") issued an extensive 816-page opinion finding that all 40 of the asserted claims contained in the seven asserted patents are valid, and that ClearCorrect infringes 37 of the 40 claims. Pursuant to ITC procedure, the Commission elected to review the ALJ's Initial Determination. 

About Align Technology, Inc.
Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign system, which provides dental professionals with a range of treatment options for adults and teenagers. The Company also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Visit www.aligntech.com for more information.

For additional information about Invisalign or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero, please visit www.itero.com

View Comments (0)